Article
The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia.
Experimental hematology - 1 Nov 2007
Nagai Sumimasa, Ichikawa Motoshi, Takahashi Tsuyoshi, Sato Hiroyuki, Yokota Hiromitsu, Oshima Kumi, Izutsu Koji, Hangaishi Akira, Kanda Yoshinobu, Motokura Toru, Chiba Shigeru, Yatomi Yutaka, Kurokawa Mineo
Abstract excerpt
OBJECTIVE: Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease (SM-AHNMD) is a distinct entity that was defined by World Health Organization. Systemic mastocytosis with acute myeloid leukemia (AML) is frequently seen among SM-AHNMD. However, the pathogenesis or origin of neoplastic mast cells has not been fully elucidated in this category of diseases. METHODS: We examined KIT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
